Coalition for Pulmonary Fibrosis - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

Coalition for Pulmonary Fibrosis

Description:

Second Wind Lung Transplant Association. The Fred J. Brotherton Charitable Foundation. Pulmonary Fibrosis Association (1996-2003) American Lung Association Chapters ... – PowerPoint PPT presentation

Number of Views:110
Avg rating:3.0/5.0
Slides: 27
Provided by: markas2
Category:

less

Transcript and Presenter's Notes

Title: Coalition for Pulmonary Fibrosis


1
www.coalitionforpf.org (888) 222-8541
2
Were here for You!
  • 11,000 patient members and growing
  • Creating More than 40 Patient Support Groups
  • Providing resources, referrals, information for
    more than 30,000 patients and families
  • Giving Free brochures to doctors and patients
  • Funding research
  • Raising Money for patient support and research
  • Advocating in Washington

3
CPF Goals Objectives
  • Accelerate research efforts to find new
    treatments, or a cure, for IPF
  • Increase public awareness of PF
  • Educating, supporting, and advocating for the
    community of patients and families fighting IPF
    and medical professionals
  • Improve detection, diagnosis and treatment of PF
    in the medical community

www.coalitionforpf.org (888) 222-8541
4
Nonprofit Partners Nationwide
  • The American Thoracic Society
  • The Anne Harroun Landgraf Foundation
  • Mary D. Harris Memorial Foundation
  • The Pulmonary Paper
  • Caring Voice Coalition
  • AARDA/NCAPG
  • Second Wind Lung Transplant Association
  • The Fred J. Brotherton Charitable Foundation
  • Pulmonary Fibrosis Association (1996-2003)
  • American Lung Association Chapters
  • 30 medical and research institutions nationwide
  • Everything we do is only possible through the
    generous support of the community we serve.
    Marvin Schwarz, MD - CPF Chairman

www.coalitionforpf.org (888) 222-8541
5
They say IPF is Rare
  • But the Yellow-tailed Woolly Monkey is really
    rare with 250 of them in the Peruvian Andes.

6
IPF More Common than Ever
  • The population of Columbia, SC is nearly the same
    as the number affected by IPF
  • Still considered a rare disease (disease that
    affects less an 200,000 people)
  • 128,000 cases
  • 48,000 new cases each year
  • Prevalence and incidence
  • on the rise

7
What is Awareness of IPF?
  • Recent CPF-funded survey of 2,000 American adults
  • While 96 of public has heard of Asthma, 88 CF
    and 85 Lou Gehrigs disease, only 29 had heard
    of IPF roughly 20 recognized it by name- only,
    and had no knowledge of the disease
  • 6 of respondents knew someone with IPF (family,
    friend)
  • Given basic information about incidence and
    prevalence of IPF when compared to other rare
    diseases (CF, ALS), 85 agreed that IPF should
    receive more federal funding for research

www.coalitionforpf.org (888) 222-8541
8
My Family and IPF
  • Five Siblings Died in 10 Years

9
Services in High Demand
  • Free Resource Kit for IPF patients and families,
    including all educational materials (Lets Talk
    About IPF, Lung Transplantation, Pulm Rehab,
    Clinical Trials)
  • Comprehensive Website for patients and medical
    professionals www.coalitionforpf.org
  • 40 Support Groups Nationwide
  • Living With IPF Seminars
  • Patient mentoring, counseling, program referrals,
    transplant education support

www.coalitionforpf.org (888) 222-8541
10
Professional Education
  • Basic Research Questionnaire (2003-Present)
  • -accepted for publication in Respiratory Medicine
    10/06
  • Critical Assessment of Treatment Options for
    IPF -Published 10/05 in J. Vasculitis,
    Sarcoid. and DLD
  • Detection and diagnosis Monograph (2002)
  • American Journal of Nursing Mon. (2002)
  • Public Opinion Survey (Fall, 2005)
  • What if IPF Medical Journal Advertorials

www.coalitionforpf.org (888) 222-8541
11
Funding Emerging Research
  • 2006 BIG Ball approx. 260,000 raised!
  • 60,000 Grant to University of Michigan
    (2/2005)
  • Investigating role of circulating fibrocytes in
    IPF
  • Investigating downregulation of TGF-b to slow
    disease progression
  • 60,000 Grant to UCLA
  • 43,000 Grant to UC
  • CPF/ATS Partnership Grant for Translational
    Research 100,000 grant 2007-2008

www.coalitionforpf.org (888) 222-8541
12
CPF Research Questionnaire
  • Recently published online in Respiratory Journal
    print issue expected this summer
  • Established in October 2003 by private restricted
    grant
  • Accurately represent the experiences of our
    members
  • Identify patient and professional education
    needs
  • Advance research efforts to find a cure for IPF
    Through NIH, Industry, Medical Center Clinical
    Trial Recruitment

www.coalitionforpf.org (888) 222-8541
13
Research Questionnaire
  • Diagnostic Information
  • 15 of patients with IPF had not had their
    diagnosis confirmed by HRCT or surgical lung
    biopsy
  • 44 of patients diagnosed with IPF within one
    year of having symptoms

www.coalitionforpf.org (888) 222-8541
14
Research Questionnaire
  • 55 of respondents initially misdiagnosed with
    another respiratory condition before being
    diagnosed with IPF
  • Of this subset of respondents
  • 17 were initially misdiagnosed with Bronchitis
  • 13 with an unspecified respiratory ailment
  • 12 with Asthma
  • 7 with COPD, 6 Emphysema

www.coalitionforpf.org (888) 222-8541
15
Research Questionnaire
  • Potential Causes
  • 14 of respondents have associated rheumatoid
    arthritis (RA) 53 GERD
  • 67 of respondents indicated that they had smoked
    cigarettes
  • Median length of time 22 years, and the median
    time of cessation was 19 years before diagnosis

www.coalitionforpf.org (888) 222-8541
16
  • Help raise awareness for IPF among
    policymakers in your state and in Washington
    (letters, emails and phone calls)
  • Urge members of Congress to support funding for
    IPF education and research efforts
  • Monitor and respond to legislation that impacts
    the IPF community
  • Support your local medical centers!

www.coalitionforpf.org (888) 222-8541
17
CPF on the Hill
  • Volunteer to come to DC
  • If you cant come, write your Members of Congress
    in support of CPFs efforts!

18
2007 Campaign ACT
  • National IPF Awareness Week 2007
  • Sept. 22-29
  • IPF Specific Legislation being reintroduced in
    House and Senate (Rep. Nathan Deal, Sen. Norm
    Coleman)
  • Ending the Medicare 24 Month Waiting Period Act
    introduced by Rep. Gene Green in House expect to
    be reintroduced in Senate by Sen. Bingaman
  • Pulmonary Rehabilitation Legislation (S. 329/H.R.
    552)
  • Patient oxygen rights

www.coalitionforpf.org (888) 222-8541
19
IPF Specific Legislation
  • HR 178 passed House in 2005 with help from late
    Congressman Charlie Norwood
  • S. 236 passed Senate in spring of 2006 with help
    from Senator Coleman
  • BUT the bills will be reintroduced because of
    difference in language
  • PLEASE call or mail a letter to your Members of
    Congress in support of this legislation

20
Ending the Medicare Wait Period
  • When Medicare was expanded in 1972 to include
    people who have significant disabilities,
    lawmakers created a Medicare waiting period.
    Before they can get Medicare coverage, people
    with disabilities must first receive Social
    Security Disability Insurance (SSDI) for 24
    months. Generally, SSDI begins five months after
    an individuals disability has been certified. As
    a result, people with disabilities face three
    consecutive waiting periods prior to getting
    health coverage.
  • IPFs rapid progression yields a median survival
    rate of fewer than three years, yet IPF patients
    must wait two years in some cases all of their
    remaining life before they can qualify for
    Medicare coverage.
  • Congress can help ease the burden of this
    terrible disease by passing H.R. 2869/S.1217 and
    giving IPF patients and others with
    life-threatening diseases immediate access to
    Medicare.
  • There is already one important exception to the
    24-month waiting period and that is for
    individuals with Lou Gehrigs disease (ALS), a
    neuromuscular disease affecting approximately
    30,000 people. The ALS exception passed Congress
    in December 2000 and went into effect July 1,
    2001. While the ALS exception is appropriate,
    its important to note that more new cases of IPF
    are diagnosed in this country each year (48,000)
    than there are total cases of ALS, yet the end
    result for both diseases remain inextricably the
    same.

21
Pulmonary Rehab Legislation
  • Problem Having no national coverage policy for
    pulmonary rehabilitation means that beneficiaries
    in some regions have no access to this important
    therapeutic benefit.
  • Legislation This bipartisan legislation would,
    establish pulmonary rehabilitation in its own
    unique benefit category and lead CMS to
    promulgate a national coverage policy that
    ensures access to this scientifically proven
    medical therapy for Medicare beneficiaries
    suffering from COPD and other respiratory
    disorders.

22
Ways the CPF is Helping
  • EVENTS LIKE THIS ONE!

23
CPF Accomplishments
  • Now in its 6th year, the CPF remains committed to
    providing our members, and all those fighting
    IPF, with the tools and resources they need to
    combat this devastating disease, while advocating
    on their behalf for expanded research efforts to
    find a cure.
  • An abbreviated list of our achievements includes
  • Awarding research grants to leading medical
    centers to advance new approaches to
    understanding and treating IPF, examples include
    a 100,000 partnership grant with the American
    Thoracic Society, a 59,000 grant to the David
    Geffen School of Medicine, a 60,000 grant to the
    University of Michigan Health System, and
    110,000 in grants to the University of Chicago
    (visit our Web page for complete list)
  • Providing supportincluding IPF resources,
    physician referrals, free educational materials,
    patient resources and supportto tens of
    thousands of patients and families nationwide
  • Advancing our national advocacy program, campaign
    ACT, through National IPF Awareness Weeks,
    advocating for patients through more than 200
    meetings with Members of Congress in Washington,
    D.C., successfully advocating for the passage of
    H.R. 178 recognizing IPF and the need for
    increased education, awareness and research
  • Partnered with more than 30 of the nations
    leading IPF treatment and research centers to
    improve disease education and awareness, and
    assist with patient recruitment for clinical
    trials
  • Providing free IPF education seminars for
    thousands of patients and their families in
    partnership with medical centers around the
    country,
  • Establishing 40 IPF support groups nationwide
  • Distributing CPF Resource Kits free of charge to
    thousands of newly diagnosed patients and their
    families
  • Providing a comprehensive Web site
    (www.coalitionforpf.org) with information,
    resources and services for pulmonary fibrosis
    patients as well as medical professionals.

24
What you can do!
  • Hold a local fundraiser ask for a free
    fundraising kit from the CPF to get started!
  • Organize a support group (if you dont have one)
    with your local medical center or rehabilitation
    department
  • Contact members of your local media (ask the CPF
    for a free media kit) Tell your story!
  • Do a mail/email/phone campaign to your friends
    and family to contact their members of Congress
  • Let the CPF know what you are doing we can
    include it in our newsletter and website
  • The CPF depends on patient and family support.
    Contribute to the CPF and ask others to do the
    same!

25
Thank you!
  • Thanks to Dr. Steven Sahn and MUSC for hosting
    the event today!
  • Thank you to the INCREDIBLE Ruth Oser!!
  • Thank you Patients!
  • Thank you Family Members and Caregivers!

26
Contact Information
Web www.coalitionforpf.org Email info_at_coalit
ionforpf.org Phone (888) 222-8541 Address 16
59 Branham Ln Suite F, 227 San Jose, CA
95118 Contacts Mark Shreve, CEO Mishka Michon,
Exec. VP, Development Teresa Geiger, VP Patient
Education Advocacy
www.coalitionforpf.org (888) 222-8541
Write a Comment
User Comments (0)
About PowerShow.com